![]() |
MEP Heart Group |
![]() |
|
|
The number 1 killer in Europe - A need for action Cardiovascular disease (CVD) is the main cause of death and disability in Europe and accounts for over 2 million deaths in the EU 27 each year, nearly half of all deaths in Europe. In response to this, the European Heart Network (EHN) and the European Society of Cardiology (ESC) are committed to identifying specific areas of policies and public health interventions which can contribute to preventing avoidable deaths and disabilities from CVD. EHN’s and ESC’s close collaboration with MEPs on cardiovascular health in the context of the Public Health Action Programme and the Cardiovascular Health Resolution have increasingly highlighted the importance of an ongoing dialogue about addressing Europe’s number 1 killer. Several initiatives currently exist to provide Member States with the appropriate tools to help reduce the burden of this disease. These include the European Heart Health Charter, the EuroHeart Project, the EP Resolution on action to tackle cardiovascular disease and the revised European Guidelines on CVD prevention in clinical practice. Structure The Members of the European Parliament (MEP) Heart Group is a forum which provides MEPs with an opportunity to generate dialogue, outreach and activities at EU and Member State level. It is made up of MEPs who have an interest in addressing CVD in the EU and in contributing to initiatives which aim to reduce the burden of this disease. The MEP Heart Group is led by two Co-Chairs, Linda McAvan MEP and Dirck Sterckx MEP. Objective The main objective of the group is to promote measures that will help reduce the burden of CVD in the EU and raise awareness of the disease amongst target audiences through a series of dedicated activities. Some of these activities may include:
Funding The MEP Heart Group is entirely funded by the EHN and the ESC. Secretariat All enquiries regarding the MEP Heart Group can be sent to: secretariat@mepheartgroup.eu The MEP Heart Group works in collaboration with the EHN and the ESC:
All enquiries regarding EHN can be addressed to: All enquiries regarding ESC can be addressed to: |
|||